Treatment of osteoarthritis with autologous and micro-fragmented adipose tissue

Author: Blønd
Year: 2019

The Regenerative Clinic's view on this research

“Twenty patients were included in the study and all participated in the follow-up. Only one adverse event was registered; a patient complaint of cosmetic changes to the abdominal subcutaneous tissue. The improvements in KOOS were significant at all follow-up. At one year, KOOS pain had improved by 14 points, symptoms by seven, activity of daily living by 13, sports by 19 and quality of life by 15. The intra-articular injection of autologous, micro-fragmented adipose tissue for treatment of knee OA seems safe. Randomised controlled trials are needed to elucidate the efficacy of the treatment.”

Osteoarthritis (OA) is the leading cause of disability in elderly people. Several non-invasive solutions have been proposed with varying success rates. Recently, new therapeutic approaches, such as the use of minimally manipulated tissue products, have gained increasing popularity. The purpose of this study was to investigate the safety and feasibility of a single intra-articular injection of autologous, micro-fragmented adipose tissue in patients with knee OA.

The study was performed as a prospective cohort study. Micro fragmented adipose tissue was obtained using a minimal manipulation technique (Lipogems®). The safety of the procedure was evaluated by recording the type
and incidence of any adverse events at three months. The clinical outcomes were determined using the Knee injury
and Osteoarthritis Outcome Score (KOOS) scale at three, six and 12 months of follow-up.
RESULTS: Twenty patients were included in the study and all participated in the follow-up. Only one adverse event was registered; a patient complaint of cosmetic changes to the abdominal subcutaneous tissue. The improvements in KOOS were significant at all follow-up. At one year, KOOS pain had improved by 14 points, symptoms by seven, activity of daily living by 13, sports by 19 and quality of life by 15.

The intra-articular injection of autologous, micro-fragmented adipose tissue for treatment of knee OA
seems safe. Randomised controlled trials are needed to elucidate the efficacy of the treatment.

TRIAL REGISTRATION: This study was registered in ClinicalTrials.gov (NCT02697682).

https://www.ncbi.nlm.nih.gov/pubmed/31571571

Get in touch

Find your clinic

We offer appointments nationwide and now working with partners abroad providing cutting edge Regenerative Medicine to patients in Dubai, Australia, Spain and Pakistan.

Sign-up to receive our recent news and the latest developments in regenerative medicine.

Join us for the first of our webinars on Wednesday 1st April at 5:30pm, when Professor Adrian Wilson will be explaining how regenerative treatments such as Lipogems® can reduce pain, increase mobility and even avoid the need for a knee replacement.

To book a place CLICK HERE we have limited spaces available.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at info@theregenerativeclinic.co.uk. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.